Bio Essence Corp Cash And Cash Equivalents At Carrying Value

• Bio Essence Corp showed an increase of +1,102.6% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
• This data is from Bio Essence Corp's annual report (Form 10-K), filed with the SEC on March 28, 2025.
• XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2020: $9.9 thousand | Q2 2020: $84.3 thousand | Q3 2020: $485.00 | Q1 2021: $10.3 thousand | Q2 2021: $8.2 thousand | Q3 2021: $26.7 thousand | Q1 2022: $225.00 | Q2 2022: $121.00 | Q3 2022: $572.00 | Q1 2023: $127.00 | Q2 2023: $541.00 | Q3 2023: $89.00 | Q1 2024: $23.00 | Q3 2024: $29.8 thousand | Q4 2024: $1.4 thousand | Q3 2025: $28.7 thousand.
• Over the full 6 years of available data (2019 to 2024), Bio Essence Corp's Cash And Cash Equivalents At Carrying Value has declined by 91.5%.
• Historical annual values: Fiscal year 2024: $1.4 thousand | Fiscal year 2023: $114.00 | Fiscal year 2022: $6.3 thousand | Fiscal year 2021: $303.00 | Fiscal year 2020: $5.3 thousand | Fiscal year 2019: $16.2 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026